Zobrazeno 1 - 10
of 28
pro vyhledávání: '"José D. Debes"'
Autor:
María Belén Pisano, Viviana E. Ré, Enrique Carrera, Domingo Balderramo, Jhon Prieto, Javier Díaz-Ferrer, Marco Arrese, Angelo Z. Mattos, José D. Debes, Andre Boonstra
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100990- (2023)
Introduction and Objectives: Worldwide, there is incomplete information about the epidemiology of hepatitis D virus (HDV), a hepatotropic satellite pathogen with an RNA genome, which requires the hepatitis B virus (HBV) as a collaborating agent for i
Externí odkaz:
https://doaj.org/article/9567b90727824824a6c9c450b5e726a4
Autor:
Gonzalo M. Castro, María J. Sosa, Paola E. Sicilia, María I. Riberi, Claudia Moreno, Rodolfo Cattaneo, José D. Debes, María G. Barbás, Analía E. Cudolá, María B. Pisano, Viviana E. Ré
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
IntroductionGenomic analysis of hepatitis B virus (HBV) identifies phylogenetic variants, which may lead to distinct biological and clinical behaviors. The satellite hepatitis D virus (HDV) may also influence clinical outcomes in patients with hepati
Externí odkaz:
https://doaj.org/article/8181c536ece04dbeb00e4fcd096294a6
Autor:
Siyu Fu, Teoman Deger, Ruben G. Boers, Joachim B. Boers, Michael Doukas, Joost Gribnau, Saskia M. Wilting, José D. Debes, Andre Boonstra
Publikováno v:
Cancers, Vol 15, Iss 19, p 4784 (2023)
Aberrant DNA methylation changes have been reported to be associated with carcinogenesis in cirrhotic HCC, but DNA methylation patterns for these non-cirrhotic HCC cases were not examined. Therefore, we sought to investigate DNA methylation changes o
Externí odkaz:
https://doaj.org/article/56572e7323f84f81ad2bc98571fe36aa
Autor:
José D. Debes, Pablo A. Romagnoli, Jhon Prieto, Marco Arrese, Angelo Z. Mattos, André Boonstra, on behalf of the ESCALON Consortium
Publikováno v:
Cancers, Vol 13, Iss 7, p 1681 (2021)
Hepatocellular carcinoma (HCC) is a leading cause of global cancer death. Major etiologies of HCC relate to chronic viral infections as well as metabolic conditions. The survival rate of people with HCC is very low and has been attributed to late dia
Externí odkaz:
https://doaj.org/article/b6feb36527a649e2a168531ba5c3e258
Autor:
María Belén Pisano, Christopher Campbell, Chimaobi Anugwom, Viviana Elizabeth Ré, José D Debes
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272809 (2022)
In the United States (U.S.), a hepatitis E virus (HEV) seroprevalence between 6 and 21% has been described, with a decreasing trend. We aimed to investigate HEV infection in the U.S. population from 2009 to 2016, and examine the differences in seropr
Externí odkaz:
https://doaj.org/article/cf57175d0f274a2793dc6434bda29c96
Autor:
Siyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z. Mattos, Marco Arrese, Enrique Carrera, Jeffrey Oliveira, Jose D. Debes, Andre Boonstra
Publikováno v:
Annals of Hepatology, Vol 29, Iss 2, Pp 101181- (2024)
Introduction and Objectives: Tolloid like protein 1 (TLL1) rs17047200 has been reported to be associated with HCC development and liver fibrosis. However, to our knowledge, no studies have been performed on Latin Americans and comparative differences
Externí odkaz:
https://doaj.org/article/87c2ca1a36984a3c909cee5eafd799ed
Publikováno v:
Annals of Hepatology, Vol 28, Iss 6, Pp 101149- (2023)
Externí odkaz:
https://doaj.org/article/92bdd9df5a40487cb6a33be997e867b0
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100903- (2023)
Externí odkaz:
https://doaj.org/article/efd90f05a9554cf09a4256fb8f2e7288
Autor:
Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, Domingo Balderramo, Enrique Carrera, Jose D. Debes
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100876- (2023)
Introduction and Objectives: Most epidemiological data on hepatocellular carcinoma (HCC) originate from resource-rich countries. We have previously described the epidemiology of HCC in South America through the South American Liver Research Network.
Externí odkaz:
https://doaj.org/article/71818f7355354ce2b8fe188e2c112d8a
Autor:
Elizabeth S. Aby, Ghady Moafa, Nyan Latt, Mohammad T. Sultan, Paula A. Cacioppo, Sonal Kumar, Raymond T. Chung, Patricia P. Bloom, Jenna Gustafson, Michael Daidone, Zoe Reinus, Jose D. Debes, Sunny Sandhu, Aalam Sohal, Sameeha Khalid, Marina Roytman, Andreea Maria Catana, Kara Wegermann, Rotonya M. Carr, Yedidya Saiman, Ihab Kassab, Vincent L. Chen, Atoosa Rabiee, Carly Rosenberg, Veronica Nguyen, Christina Gainey, Kali Zhou, Kenneth Chavin, Blanca C. Lizaola-Mayo, David M. Chascsa, Lee Varelas, Akshata Moghe, Renumathy Dhanasekaran
Publikováno v:
Hepatology Communications, Vol 7, Iss 1, Pp e8874-e8874 (2023)
Background:. COVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited. Methods:. We conducted a multice
Externí odkaz:
https://doaj.org/article/c236dde342a743419230b5c9caa718bb